In last trading session, BioXcel Therapeutics Inc. (NASDAQ:BTAI) saw 3.88 million shares changing hands with its beta currently measuring 0.99. Company’s recent per share price
BioXcel Therapeutics Inc. (NASDAQ:BTAI) has a beta value of 1.00 and has seen 1.33 million shares traded in the last trading session. The company, currently
During the last session, BioXcel Therapeutics Inc. (NASDAQ:BTAI)’s traded shares were 1.42 million, with the beta value of the company hitting 0.98. At the end
In last trading session, BioXcel Therapeutics Inc. (NASDAQ:BTAI) saw 0.88 million shares changing hands with its beta currently measuring 1.07. Company’s recent per share price
BioXcel Therapeutics Inc. (NASDAQ:BTAI) has a beta value of 1.06 and has seen 1.28 million shares traded in the last trading session. The company, currently
During the last session, BioXcel Therapeutics Inc. (NASDAQ:BTAI)’s traded shares were 1.57 million, with the beta value of the company hitting 1.05. At the end